Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Makers Press For U.S. Trade Sanctions On Thailand

This article was originally published in PharmAsia News

Executive Summary

Drug makers are about to press the U.S. Trade Representative to impose sanctions on Thailand for refusing to drop its compulsory license moves to drive down the price of certain medicines. The director general of Thailand's Intellectual Property Department said the Pharmaceutical Research and Manufacturers of America, which met in Singapore recently, had threatened a strong lobbying effort to get the U.S. policy change. The sanction process envisioned would reduce Thailand from the Priority Watch List where it is now to Priority Foreign Country that makes a nation subject to trade sanctions. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066771

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel